Tag: Covaxin vaccine

The drug regulator of India has approved the extension of shelf life of Bharat Biotech's Covid-19 vaccine Covaxin up to 12 months.

Bharat Biotech's Covaxin was granted Emergency Use Authorisation on Wednesday evening after several rounds of discussions on the inactivated-virus vaccine made in India.

HYDERABAD: Bharat Biotech, the developer of indigenously developed C-19 vaccine Covaxin, has completed the Phase II/III trials on children in the 2-18 years age...

New Delhi : World Health Organisation's (WHO) approval for the emergency use authorisation (EUA) to C-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech,...

PUNE: A person would have to take two doses of Covaxin even after recovering from Covid-19 for being considered as a fully vaccinated individual, a Union health...

Dr Krishna Ella, chairman & managing director, Bharat Biotech has given recognition to Gujarat Food and Drug Control Administration (FDCA) commissioner Dr...

As the country is ramping up its inoculation drive, the Centre on Tuesday said monthly production capacity of Covishield is projected to be increased...

Brazil has suspended the clinical trials of Bharat Biotech's C-19 vaccine, Covaxin after the Hyderabad based company terminated agreement with its partner...

New Delhi: The phase-three human clinical trial of indigenously developed C-19 virus vaccine candidate Covaxin began at the AIIMS here on Thursday with Dr M V Padma Srivastava,...

New Delhi: Bharat Biotech is planning to launch its vaccine for C-19 in the second quarter next year if it gets the requisite approvals...